Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis
Stock Information for Aquestive Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.